177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo-Reference-Cited by-同舟云学术

177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo

Published:2005-04 Issue:3 Volume:32 Page:269-278
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Michel Rosana B.,Andrews Philip M.,Rosario Adriane V.,Goldenberg David M.,Mattes M. Jules

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference32 articles.

1. Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody;Wagner;J. Nucl. Med.,2002

2. Pivotal study of iodine I-131 tositumomab for chemotherapy–refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas;Kaminski;J. Clin. Oncol.,2001

3. Electron dosimetry for radioimmunotherapy: Optimal electron energy;Sastry;Radiat. Prot. Dosimetry,1985

4. MIRD cellular S values;Goddu,1997

5. Radionuclide-antibody conjugates for single-cell cytotoxicity;Mattes;Cancer,2002

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics of Hematologic Disorders;Nuclear Medicine and Immunology;2021-11-25

2. Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies;Frontiers in Chemistry;2020-07-07

3. Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates;Peptide Science;2020-05

4. A systematic study on the utility of CHX-A’’-DTPA-NCS and NOTA-NCS as bifunctional chelators for 177 Lu radiopharmaceuticals;Applied Radiation and Isotopes;2017-09

5. Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model;Cancer Letters;2016-10